Agios Pharmaceuticals Inc. (AGIO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
Q4  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 26,960 | 0.01 | |
Q2  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 4,042 | 0.00 | |
Q4  2019 | |||||
≡ | Meridian Contrarian Fund | Sell 100.00% | 62,000 | 0.38 | |
Q2  2019 | |||||
≡ | Meridian Contrarian Fund | Reduce 54.07% | 73,000 | 0.67 | |
Q2  2018 | |||||
≡ | Leon Cooperman | Sell 100.00% | 45,000 | 0.14 | |
≡ | Meridian Contrarian Fund | Reduce 13.64% | 18,000 | 0.24 | |
Q1  2018 | |||||
≡ | Meridian Contrarian Fund | Reduce 3.65% | 5,000 | 0.07 | |
Q4  2016 | |||||
≡ | Meridian Contrarian Fund | Reduce 26.04% | 22,000 | 0.18 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.